Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Delinea has signed a definitive agreement to acquire StrongDM, combining Delinea's PAM with StrongDM’s JIT runtime authorization capabilities.
-
NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Mount Logan Capital Inc. (Nasdaq: MLCI) (“Mount Logan”, “MLCI”, or the “Company”) today announced the commencement of a registered underwritten public...
-
Five Arrows will be making a majority investment to drive Blue Mountain's next phase of growth.
-
Luminary unveils secure Physics AI models for drones, subs, and pumps to accelerate U.S. defense tech and keep forces ahead by air, land, and sea.
-
NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) today closed its recently announced public offering of...
-
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Valeo 2022-2025 Labor & Employment Law Firm Hourly Rate Report" report has been added to ResearchAndMarkets.com's offering. The Valeo 2022 –...
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Legal Services Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The report elucidates...
-
Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) announces the pricing of its previously announced public...
-
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants